Işıl Altıntaş
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Biomaterials top 10%
- Oncology
- Immunology
- Co-authors
- Raymond M. SchiffelersRobbert J. KokWim E. HenninkPaul M.P. van Bergen en HenegouwenRoy van der MeelRaimond HeukersGert StormRob Haselberg
- Topics
- Monoclonal and Polyclonal Antibodies Research (6 papers)Nanoparticle-Based Drug Delivery (5 papers)Glycosylation and Glycoproteins Research (4 papers)
- Journals
- Angewandte Chemie International EditionSHILAP Revista de lepidopterologíaBiomaterials
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Işıl Altıntaş
13 papers receiving 533 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 263
- Radiology, Nuclear Medicine and Imaging 248
- Biomaterials 157
- Oncology 134
- Immunology 132
Countries citing papers authored by Işıl Altıntaş
This map shows the geographic impact of Işıl Altıntaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Işıl Altıntaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Işıl Altıntaş more than expected).
Fields of papers citing papers by Işıl Altıntaş
This network shows the impact of papers produced by Işıl Altıntaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Işıl Altıntaş. The network helps show where Işıl Altıntaş may publish in the future.
Co-authorship network of co-authors of Işıl Altıntaş
This figure shows the co-authorship network connecting the top 25 collaborators of Işıl Altıntaş. A scholar is included among the top collaborators of Işıl Altıntaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Işıl Altıntaş. Işıl Altıntaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 61 | |
| 5 | 31 | |
| 6 | 71 | |
| 7 | 30 | |
| 8 | 97 | |
| 9 | 110 | |
| 10 | 16 | |
| 11 | 34 | |
| 12 | 84 | |
| 13 | 2 |
About Işıl Altıntaş
Işıl Altıntaş is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 13 papers that have together received 541 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Biomaterials (157 citations), Radiology, Nuclear Medicine and Imaging (248 citations) and Immunology (132 citations). Işıl Altıntaş has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Raymond M. Schiffelers, Robbert J. Kok, Wim E. Hennink, Paul M.P. van Bergen en Henegouwen, Roy van der Meel, Raimond Heukers, Gert Storm, Rob Haselberg, Rob C. Roovers and Sabrina Oliveira. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.